Seegene USA, Inc. Announces Collaboration with Microbix Biosystems Inc.
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy Expanded Collaboration to Improve Syndromic Infectious Disease Testing IRVINE, CA, USA, December 14, 2023 /EINPresswire.com/ -- Seegene USA, Inc. (“Seegene USA”), a leading developer of multiplex…
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.
Company expands presence and support in US market. Proprietary TOCE™ technology overcomes PCR testing limitations for high multiplex applications. IRVINE, Calif., January 5, 2023 (Newswire.com) - Seegene Technologies, Inc., a subsidiary of Seegene Inc., South Korea's…
Seegene Announces Submission to U.S. FDA for Emergency Use Authorization of Its Allplex™ SARS-CoV-2/FluA/FluB/RSV Assay
Published on: BUSINESS WIRE Real-time test differentiates influenza A & B, RSV and COVID-19 SEOUL, South Korea (March 1, 2021)— Seegene Inc., (KQ096530), a biotechnology company specializing in molecular diagnostics, has submitted its Allplex™ SARS-CoV-2/FluA/FluB/RSV…